Repurposing the yellow fever vaccine for intratumoral immunotherapy

Por Aznar, Maria Angela, Molina, Carmen, Teijeira, Alvaro, Rodriguez, Inmaculada, Azpilikueta, Arantza, Garasa, Saray, Sanchez‐Paulete, Alfonso R, Cordeiro, Luna, Etxeberria, Iñaki, Alvarez, Maite, Rius‐Rocabert, Sergio, Nistal‐Villan, Estanislao, Berraondo, Pedro, Melero, Ignacio
Publicado no EMBO Mol Med (2019)

Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires Batf3-dependent dendritic cells

Por Sánchez-Paulete, Alfonso R., Cueto, Francisco J., Martínez-López, María, Labiano, Sara, Morales-Kastresana, Aizea, Rodríguez-Ruiz, María E., Jure-Kunkel, Maria, Azpilikueta, Arantza, Aznar, M. Angela, Quetglas, José I., Sancho, David, Melero, Ignacio
Publicado no Cancer Discov (2015)

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism

Por Labiano, Sara, Palazón, Asis, Bolaños, Elixabet, Azpilikueta, Arantza, Sánchez-Paulete, Alfonso R., Morales-Kastresana, Aizea, Quetglas, Jose I., Perez-Gracia, José L., Gúrpide, Alfonso, Rodriguez-Ruiz, Maria, Aznar, M. Angela, Jure-Kunkel, Maria, Berraondo, Pedro, Melero, Ignacio
Publicado no Oncoimmunology (2015)

Cellular cytotoxicity is a form of immunogenic cell death

Por Minute, Luna, Teijeira, Alvaro, Sanchez-Paulete, Alfonso R, Ochoa, Maria C, Alvarez, Maite, Otano, Itziar, Etxeberrria, Iñaki, Bolaños, Elixabet, Azpilikueta, Arantza, Garasa, Saray, Casares, Noelia, Luis Perez Gracia, Jose, Rodriguez-Ruiz, Maria E, Berraondo, Pedro, Melero, Ignacio
Publicado no J Immunother Cancer (2020)

Functional expression of CD137 (4-1BB) on T helper follicular cells

Por Alfaro, Carlos, Echeveste, Jose I, Rodriguez-Ruiz, Maria E, Solorzano, Jose L, Perez-Gracia, Jose L, Idoate, Miguel A, Lopez-Picazo, Jose M, Sanchez-Paulete, Alfonso R, Labiano, Sara, Rouzaut, Ana, Oñate, Carmen, Aznar, Angela, Lozano, Maria D, Melero, Ignacio
Publicado no Oncoimmunology (2015)

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes

Por Labiano, Sara, Meléndez-Rodríguez, Florinda, Palazón, Asís, Teijeira, Álvaro, Garasa, Saray, Etxeberria, Iñaki, Aznar, M. Ángela, Sánchez-Paulete, Alfonso R., Azpilikueta, Arantza, Bolaños, Elixabet, Molina, Carmen, de la Fuente, Hortensia, Maiso, Patricia, Sánchez-Madrid, Francisco, de Landázuri, Manuel Ortiz, Aragonés, Julián, Melero, Ignacio
Publicado no Oncoimmunology (2017)

Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses

Por Ballesteros-Briones, Maria Cristina, Martisova, Eva, Casales, Erkuden, Silva-Pilipich, Noelia, Buñuales, Maria, Galindo, Javier, Mancheño, Uxua, Gorraiz, Marta, Lasarte, Juan J., Kochan, Grazyna, Escors, David, Sanchez-Paulete, Alfonso R., Melero, Ignacio, Prieto, Jesus, Hernandez-Alcoceba, Ruben, Hervas-Stubbs, Sandra, Smerdou, Cristian
Publicado no Mol Ther (2019)

DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells

Por Cueto, Francisco J, del Fresno, Carlos, Brandi, Paola, Combes, Alexis J., Hernández-García, Elena, Sánchez-Paulete, Alfonso R, Enamorado, Michel, Bromley, Christian P, Gomez, Manuel J, Conde-Garrosa, Ruth, Mañes, Santos, Zelenay, Santiago, Melero, Ignacio, Iborra, Salvador, Krummel, Matthew F., Sancho, David
Publicado no J Immunother Cancer (2021)